Barclays’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-9,788
| Closed | -$29K | – | 3993 |
|
|
2021
Q3 | $29K | Sell |
9,788
-1,805
| -16% | -$5.35K | ﹤0.01% | 3530 |
|
|
2021
Q2 | $40K | Sell |
11,593
-8,137
| -41% | -$28.1K | ﹤0.01% | 3487 |
|
|
2021
Q1 | $68K | Buy |
19,730
+11,477
| +139% | +$39.6K | ﹤0.01% | 3471 |
|
|
2020
Q4 | $159K | Sell |
8,253
-1,630
| -16% | -$31.4K | ﹤0.01% | 2803 |
|
|
2020
Q3 | $132K | Buy |
9,883
+70
| +0.7% | +$935 | ﹤0.01% | 2919 |
|
|
2020
Q2 | $415K | Buy |
9,813
+4,000
| +69% | +$169K | ﹤0.01% | 2430 |
|
|
2020
Q1 | $160K | Sell |
5,813
-7,973
| -58% | -$219K | ﹤0.01% | 2636 |
|
|
2019
Q4 | $447K | Buy |
13,786
+4,677
| +51% | +$152K | ﹤0.01% | 2749 |
|
|
2019
Q3 | $236K | Buy |
9,109
+1,632
| +22% | +$42.3K | ﹤0.01% | 2992 |
|
|
2019
Q2 | $275K | Buy |
7,477
+5,559
| +290% | +$204K | ﹤0.01% | 3030 |
|
|
2019
Q1 | $42K | Buy |
1,918
+1,316
| +219% | +$28.8K | ﹤0.01% | 3720 |
|
|
2018
Q4 | $8K | Sell |
602
-1,941
| -76% | -$25.8K | ﹤0.01% | 3621 |
|
|
2018
Q3 | $49K | Buy |
2,543
+2,046
| +412% | +$39.4K | ﹤0.01% | 3746 |
|
|
2018
Q2 | $11K | Sell |
497
-902
| -64% | -$20K | ﹤0.01% | 3881 |
|
|
2018
Q1 | $30K | Buy |
+1,399
| New | +$30K | ﹤0.01% | 3723 |
|